Acute hyperglycemic syndrome (AHS), including diabetic ketoacidosis (DKA) and a hyperosmolar hyperglycemic state (HHS), is a critical emergency requiring prompt and effective management. Intravenous ...

"An increase in blood osmolality is thought to induce thirst by activating a hyperosmolar sensor expressed in the subfornical organ (SFO), but the molecular identity of this sensor remains elusive ...

Applied Digital (NASDAQ:APLD) has just signed a deal with CoreWeave (CRWV) that could generate over $7 billion in revenues for the company in 15 years. The market has taken this news in well, and ...

Infusion centers nationwide are struggling with increasing patient volumes, staff burnout, and limited chair capacity. Chicago-based Northwestern Medicine tackled these challenges head-on at its ...

Northwell Health is continuing to expand oncology services at Long Island Jewish Medical Center with a new infusion clinic at its extension site in Greenlawn. The health system filed plans with ...

Along with this, they were also supporting liquidity through daily VRR auctions. The heavy liquidity infusion was due to existing cash in the banking system starting to fall into deficit from mid ...

All three would give Miami an infusion of talent while allowing the Heat to keep their main guys.” Markkanen would be the star addition for Miami. However, Sexton would plug a hole at the point ...

Additionally, with the growing demand for chronic disease treatments and the ageing baby boomer population, the infusion market is set for significant growth. According to the market research ...

Inserting, monitoring, and maintaining peripheral venous access is an integral component of neonatal nursing care. Although complications associated with peripheral vascular devices are typically ...

TAMPA, Fla., May 13, 2025--(BUSINESS WIRE)--Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), an ocean exploration pioneer engaged in the discovery, development and extraction of critical minerals ...

A new study published in Frontiers in Nutrition warns that people taking popular GLP-1 weight-loss drugs for obesity such as semaglutide (Ozempic) and tirzepatide (Mounjaro) may not be getting enough ...